# ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

> clinical trial · VERIFIED · 2026-06-16

Status: ACTIVE_NOT_RECRUITING · Sponsor: Acepodia Biotech, Inc. · Condition: B-cell Lymphoma

- Company: Acepodia Biotech, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05653271

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.